Edition:
United Kingdom

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

10.08USD
13 Dec 2017
Change (% chg)

$0.23 (+2.34%)
Prev Close
$9.85
Open
$9.90
Day's High
$10.17
Day's Low
$9.90
Volume
64,890
Avg. Vol
63,280
52-wk High
$17.33
52-wk Low
$8.86

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 23.01 -0.171
Jun '17 3.01 -0.694
Mar '17 3.02 -0.631
FY 2016 Dec '16 3.04 -0.626
Sep '16 13.02 -0.464
Jun '16 3.00 -0.705
Mar '16 0.00 -1.308
FY 2015 Dec '15 0.00 -0.500
Sep '15 0.00 -0.375
Jun '15 0.00 -1.453
Mar '15 0.00 -0.211
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 7 2.57 3.00 0.00 4.00
Quarter Ending Mar-18 2 13.00 23.00 3.00 --
Year Ending Dec-17 7 31.60 32.05 29.04 19.34
Year Ending Dec-18 8 16.01 42.00 0.00 20.39
Earnings (per share)
Quarter Ending Dec-17 7 -0.74 -0.67 -0.81 -0.83
Quarter Ending Mar-18 3 -0.51 -0.16 -0.73 --
Year Ending Dec-17 7 -2.24 -2.16 -2.31 -2.47
Year Ending Dec-18 8 -2.68 -1.70 -3.73 -2.71
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 21.87 100.67 5.40
Price to Book (MRQ) 5.48 13.50 5.38
Price to Tangible Book (MRQ) 5.49 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 78.85 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.30 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago 286.35 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -0.69 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -16.86 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 6.86 5.36 2.98
LT Debt to Equity (MRQ) 11.21 18.92 11.56
Total Debt to Equity (MRQ) 11.21 20.59 15.81
Interest Coverage (TTM) -- -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -419.56 -- --
EBITD - 5 Yr. Avg -- -261.11 15.24
Operating Margin (TTM) -448.70 -556.64 7.76
Operating Margin - 5 Yr. Avg. -- -279.29 10.75
Pre-Tax Margin (TTM) -441.38 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.02 11.17
Net Profit Margin (TTM) -441.38 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 173,858 25,314,503 864,673,362
Net Income/Employee (TTM) -767,370 3,332,048 101,717,513
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.08 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -37.30 -0.78 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -41.51 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -76.34 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 1.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Seres Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -16.99 -19.85 10 53
13 Week 7.00 1.79 67 61
26 Week 9.86 1.51 67 69
52 Week 4.47 -11.45 55 46
YTD 20.40 5.74 62 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 79.92%
# of Holders: 129
Total Shares Held: 32,390,071
3 Mo. Net Change: 443,810
# New Positions: 13
# Closed Positions: 12
# Increased Positions: 58
# Reduced Positions: 35
# Net Buyers: 23
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.